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Abstract Alterations in the circulating CD8+ Tcell pool,
with a loss of naïve and accumulation of effector/effector
memory cells, are pronounced in older adults. However,
homeostatic forces that dictate such changes remain in-
completely understood. This observational cross-sectional
study explored the basis for variability of CD8+ T cell
number and composition of its main subsets: naïve, central
memory and effector memory T cells, in 131 cytomegalo-
virus (CMV) seropositive subjects aged over 60 years. We
found great heterogeneity of CD8+ Tcell numbers, which
was mainly due to variability of the CD8+CD28− T cell
subset regardless of age. Analysis, by multiple regression,
of distinct factors revealed that age was a predictor for the
loss in absolute number of naïve T cells, but was not
associated with changes in central or effector memory
CD8+ Tcell subsets. By contrast, the size of CD8+ Tcells
specific to pp65 and IE-1 antigens of CMV, predicted
CD28−CD8+ T cell, antigen-experienced CD8+ T cell,
and even total CD8+ T cell numbers, but not naïve CD8+
T cell loss. These results indicate a clear dichotomy be-
tween the homeostasis of naïve and antigen-experienced
subsets of CD8+ Tcells which are independently affected,
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Introduction
Altered immunity associated with aging, commonly
defined as immunosenescence, is a potential contributor
to increased morbidity and death in old age (Pawelec
2006; McElhaney and Effros 2009). The greatest alter-
ations of the circulating T cell population are found
within the CD8+ Tcell branch and consist of an increase
in antigen-experienced T cells with a CD28- late differ-
entiated phenotype (Fagnoni et al. 1996; Weng et al.
2009) along with a shortage of naïve T cells (Fagnoni
et al. 2000). Interestingly, subjects with prior cytomeg-
alovirus (CMV) infection not only have a similar excess
of CD8+CD28− (Looney et al. 1999; Almanzar et al.
2005; Weinberger et al. 2007; Chidrawar et al. 2009;
Derhovanessian et al. 2010, 2011; Litjens et al. 2011)
and fewer CD8+ naïve T cells (Almanzar et al. 2005;
Weinberger et al. 2007; Chidrawar et al. 2009;
Derhovanessian et al. 2010, 2011; Litjens et al. 2011;
Sauce et al. 2009) in comparison with uninfected sub-
jects, but also represent the vast majority of elderly
people (Boeckh and Geballe 2011; Natali et al. 1997).
Consequently, such age-related alterations of CD8+ T
cell subsets are believed to be driven by CMV infection
(Koch et al. 2007; van de Berg et al. 2008). However,
many questions remain about effects of anti-CMVTcell
responses on T cell homeostasis in aged subjects.
One basic question concerns the distinction between
the relative effects of anti-CMV T cell responses and
aging itself since it is not entirely clear whether CD8+
subsets alterations are also due to chronological age (Pita-
Lopez et al. 2009) or rather depend solely on age-
dependent increasing prevalence of CMV seropositivity
(Weinberger et al. 2007; Chidrawar et al. 2009). Also,
there exists the formal possibility that CMV predomi-
nantly infects subjects that already exhibit subverted T
cell pools and weakened immunity, which may, or may
not, predispose them to CMV infection. Furthermore,
when considering each single CD8+ subset, it has never
been assessed whether all accumulated CD28−CD8+ T
cells seen in infected subjects can recognize CMV (Weng
et al. 2009), and whether their accumulation correlates
with the size of anti-CMV Tcell responses. In fact, CMV
might drive indirect non-specific T cell differentiation,
or accelerate age-dependent loss of homeostatic
mechanisms, or the immune response against CMV
could produce or contribute to an environment of inflam-
mation, that could intensify antigen-dependent differenti-
ation in response to other antigens. On the other hand,
with regard to naïve Tcells loss, inflated anti-CMV Tcell
responses may have a detrimental effect, but it remains to
be seen whether naïve T cell loss is related to expansion
of anti-CMV Tcell responses and whether age and CMV
infection may synergize to accelerate this loss.
Many such questions could be answered through
evaluation of the overall magnitude of CMV-specific T
cell responses, which unfortunately is an extremely
demanding task because of the breadth of such re-
sponses. Functional assays with intracellular cytokine
staining (ICS) in antigen-activated cells (Kern et al.
2000; Sylwester et al. 2005), and flow cytometry
(FCM) staining assays with peptide-MHC (pMHC)
multimers (Khan et al. 2002), both provide a partial
determination of the CMV-specific T cell responses.
Nevertheless, studies carried out so far with pMHC
multimers (Khan et al. 2002, 2004; Ouyang et al.
2004; Vescovini et al. 2004), or with functional assays
(Khan et al. 2004, 2007; Vescovini et al. 2007) both
have reported consistent and significant increases in
CD8+ CMV-specific memory/effector T cells in the
elderly in comparison with younger subjects. Such re-
sults constitute a starting point to suggest that elderly
subjects carrying CMVmay have not only altered T cell
homeostasis, but also altered immunity to heterologous
viruses and impaired responses to vaccines. These asso-
ciations are raising the appealing hypothesis that reduc-
ing the impact of CMV infection may improve immu-
nocompetence and health by anti-CMV interventions
(Demmler 2006; Moss 2010). Ultimately, to clarify this
issue, the design of interventional anti-CMV trials would
be required, but for this purpose it would be essential to
define which endpoints are clearly dependent on CMV
andmay be still reversible and possibly targeted in CMV-
seropositive subjects even in advanced aging.
The scope of this observational cross-sectional study
was to understand whether, which and how the altered
profile of naive, memory and effector CD28−CD8+
CD8+ T cell subsets in CMV-seropositive subjects aged
over 60 years could depend on anti-CMV CD8+ T cell
responses. To this end, we enumerated CD8+ T cells
producing IFN-gamma following ex vivo stimulation
with peptides covering the pp65 and IE-1 proteins, and
CD8+ Tcells identified by pMHCmultimers to individ-
ual pp65 HLA-A2 and -B7 immunodominant epitopes,
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to see their relationship with the variability of each
CD8+ T cell subset. Although analysis of this study
was limited to only a small fraction of the overall anti-
CMV CD8+ T cells response, results indicated that
numbers of anti-CMV CD8+ T cells had a significant
impact upon variability of central/effector memory
CD8+ T cells, but without significant effect on the
naïve CD8+ T cell reservoir, whose depletion worsened
simply in line with age.
Methods
Subjects
The study was performed after approval from the Ethics
Committee of the University of Parma. We contacted
subjects aged ≥60 years (range: 60–100 years) and after
written, informed consent, they received an extensive
physical examination and answered standardized ques-
tionnaires to assess clinical history, current disease, cur-
rent medication list, cognitive function, functional ac-
tivity, lifestyle and socioeconomic status. Exclusion
criteria were: evidence of endocrine, autoimmune and
neoplastic diseases, acute infections or very recent in-
fections (in the last 2 months), renal and liver failure and
the use of medications known to modulate the immune
responses (steroids, non-steroidal anti-inflammatory
agents, acetyl salicylic acid >100 mg/day or other im-
munosuppressive drugs). Blood samples were drawn
from all 131 subjects enrolled in the study, 79 females
and 52 males, to perform the laboratory analyses.
Determination of CMV-specific antibody levels
CMV-specific IgM and IgGAb levels were determined in
serum samples from all donors. Indirect chemilumines-
cence immunoassays (CLIA), were used for the quantita-
tive evaluation of anti-CMV IgM and IgG (Liaison CMV
IgM and CMV IgG assays, DiaSorin, Vercelli, Italy).
Samples were analyzed by a photomultiplier Liaison
(DiaSorin), following the manufacturer’s protocol.
Flow cytometric analysis of T cells phenotype
Surface staining was performed on heparinized whole
blood using the following mAbs: anti-CD28-FITC,
anti-CD95-PE, anti-CD3-PerCP and anti-CD8-APC or
anti-CD4-APC (all from BD Biosciences, San Jose,
CA, USA). First, 100 μl of blood was incubated with
saturating amounts of the mAbs for 20 min on ice and
then were lysed with FACS Lysing Solution (BD
Biosciences). Six-parameter FCM acquisition and analy-
sis were performed on a two-laser FACSCalibur instru-
ment (BD Biosciences) using CellQuest software (BD
Biosciences). Files were first gated on lymphocytes,
identified by characteristic forward angle and side scatter
profiles and CD3+CD8+ T cells subsets were gated into
naïve (CD28+CD95−), central memory (CM, CD28+
CD95hi), and effector/effector memory (EM, CD28−
CD95hi) subsets, as previously published in human
(Fagnoni et al. 2000) and in primate models (Pitcher
et al. 2002). Isotype-matched irrelevant antibodies were
used to set fluorescence markers and to identify non-
specific binding. To obtain the absolute numbers we used
total lymphocyte counts from quality certified clinical
laboratory analysis and FCM quantification of CD8+ T
cell frequencies. The absolute numbers of total, naïve,
CM and EM CD8+ T cells per μl of peripheral blood
were calculated multiplying lymphocyte counts by the
frequency of different subsets in the lymphocyte gate. In
the multiple regression analysis, CM and EM CD8+ T
cells were considered separately or together, as antigen-
experienced Tcells (total memory, CD95hi), as indicated.
Assessment of functional anti-CMV CD8+ T cell
responses by intracellular cytokine staining
Peripheral blood mononuclear cells (PBMCs) were ob-
tained by Ficoll density gradient centrifugation (Biocoll
Separating Solution; Biochrom AG, Berlin) from fresh-
ly drawn venous blood. After washing with phosphate-
buffered saline (PBS), PBMCs were resuspended in
RPMI 1640 medium supplemented with 10 % fetal calf
serum (FCS), 2 mmol/lL-glutamine, 100 μg/ml strepto-
mycin and 100 units/ml penicillin (complete medium).
In all experiments the cells were immediately stimulated
with PepMix pp65 and PepMix IE-1 (JPT Peptide
Technologies, Berlin, Germany), spanning the 65-kDa
lower matrix phosphoprotein and the 55-kDa
immediate-early protein 1, respectively, and consisting
of 15 amino acid long peptides, overlapped by 11 amino
acids. Stimulation and intracellular cytokine detection
was performed in accordance with the protocol recom-
mended by JPT Peptide Technologies and well de-
scribed (Vescovini et al. 2007). Briefly, 106 PBMCs
were placed in 15-ml conical polypropylene tubes
(Corning Incorporated, New York, USA) in a final
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volume of 500 μl of complete medium and incubated
with one test volume of each PepMix and 1 μg each of
the costimulatory mAbs CD28 and CD49d (BD
Biosciences). Negative controls (incubation with anti-
CD28/CD49d but not with PepMixes) were included in
every experiment to detect spontaneous production of
cytokines. After 1 h of incubation in a standard incuba-
tor (37 °C, humidified CO2 atmosphere) each tube re-
ceived 500 μl of complete medium containing the pro-
tein transport inhibitor monensin (BD Golgi Stop, BD
Biosciences). After an additional 4 h, PBMCs were
fixed, permeabilized and then stained with saturating
amounts of antibodies anti-IFN-γ, anti-CD4 and anti-
CD8 (all from BD Biosciences). The samples were
acquired and analyzed as described above. Files were
gated on lymphocytes and cytokine–secreting popula-
tions and were defined as the percentage of the
IFN-γ+events gated on CD8+ T cell population minus
the percentage of the events falling into the same region
in the corresponding control sample. We identified the
sum of the frequencies of anti-pp65 and/or anti-IE-1
IFN-γ producing CD8+ T cells as the percentages of
functional anti-CMV CD8+ among total CD8+. The
absolute numbers of anti-CMV CD8+ T cells per μl of
peripheral blood were calculated multiplying lympho-
cyte counts by the frequency of CD8+ T cells in the
lymphocyte gate and by the frequency of IFN-γ pro-
ducing cells within total CD8+.
Assessment of anti-CMV CD8+ T cell responses
by pMHC pentamer staining
All subjects were screened for HLA-A*02 and HLA-
B*07 alleles by FCM: positive donors were identified
by using R-PE-conjugated anti-HLA-A2 and FITC-
conjugated anti-HLA-B7 monoconal antibodies
(ProImmune Limited, Oxford, UK). PBMCs (1×106)
from positive subject were incubated with saturating
amounts of R-PE-conjugated HLA-A*0201/CMV
pp65(495–503) (NLVPMVATV) and HLA-
B*0702/CMV pp65(417–426) (TPRVTGGGAM)
pentamers (ProImmune). The cells were incubated for
10 min at room temperature in the dark, then washed in
a wash buffer (PBS supplemented with bovine serum
albumin and EDTA) and incubated with anti-CD3-PE-
Cy7, anti-CD8-APC and anti-CD28-FITC mAbs (B.D.
Biosciences), for 30 min on ice in the dark. The samples
were then washed and acquired by FCM. In single-
positive donors we identified the frequencies of CD8+
T cells positive for A*0201/CMV pp65(495–503) or
HLA-B*0702/CMV pp65(417–426) pentamers as the
percentage of anti-pp65pentamers+CD8+ T cells
among total CD8; in double-positive donors we identi-
fied the frequencies of CD8+ T cells positive for both
immunodominant epitopes, added them and expressed
them as the percentage of anti-pp65pentamers+CD8+ T
cells among total CD8+ T cells. The absolute numbers
per μl of peripheral blood were calculated multiplying
lymphocyte counts by the frequency of CD8+ in the
lymphocyte gate and by the frequency of anti-
pp65pentamer+CD8+ T cells within total CD8+. We
analyzed also the expression of CD28 molecule among
the anti-pp65pentamer+T cells, determining the percent-
ages and the absolute numbers of the two subsets of anti-
pp65pentamer+CD28+ CM and anti-pp65pentamer+
CD28− EM T cells.
Statistical analysis
Statistical analysis was performed using StatView and
SPSS softwares. 0.05 was the alpha level at which
p values were considered statistically significant.
CMV-specific IgG values were represented as rank-
transformed data. Correlations between age, size of
CD8+ T cell subsets and anti-CMV responses were
tested using the Spearman’s rank correlation coefficient.
In order to investigate the contribution of several vari-
ables on CD8+ T cell subsets (number of total, naïve, and
antigen-experienced CD8+ T cells), we used multiple
regression analyses. In our model-building strategy, age
and CMV infection were considered a priori as main
exposures of interest, and others predictors, identified as
the more biologically relevant among the available data,
were considered as covariates included to adjust for po-
tential sources of confounding. We examined the follow-
ing predictors: age, functional anti-CMV CD8+ T cell
absolute number, anti-pp65pentamer+T cell absolute
number, anti-CMV IgG titer, gender, educational level
and health status. In these models, educational level
(self-reported number of years spent at school) was used
as an indirect socioeconomic status indicator and the var-
iable was treated as continuous. The subject’s health status
was considered as a categorical variable, which could only
take one of two values: healthy subject/unhealthy subject.
Interview at the enrolment, physical examination, current
medication list and results of laboratory analyses were
used by trained clinicians to diagnose diseases, with the
diagnosis based on established and widely recognized
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criteria. “Healthy subjects” were defined as subjects with-
out evidence of diseases with the possible exception of
mild hypertension or osteoarthritis, without cognitive im-
pairment (Mini Mental State Examination [MMSE] >21),
without functional impairment (no more than one com-
promised activities of daily living [ADL], Katz index),
without hemato-chemical alterations and not taking any
medication with the possible exception of anti-
hypertensive therapy. “Unhealthy subjects” were defined
as subjects that did not meet one or more of the previously
indicated conditions and so could not be considered
“healthy subjects”.
We used backward elimination to identify the signif-
icant predictors and we presented multiple regression
analyses only with the significant predictors.
Results
Variability of CD8 Tcells in subjects aged over 60 years
with prior CMV infection
We studied 131 CMV-infected subjects aged over
60 years (mean age, 81.3±10.3, range 60–100), all of
whom were negative for CMV-IgM, but positive for
CMV-IgG. We first determined percentages and abso-
lute numbers of peripheral blood leukocytes, lympho-
cytes, CD3+ T cells, CD4+ T cells, CD8+ T cells
(Table 1) and among total CD8+ T cells, percentages
and numbers of three main subsets including naïve
(CD28+CD95−), CM (CD28+CD95hi) and EM
(CD28−CD95hi) (Fig. 1a). We observed wide variabil-
ity of the whole CD8+ T cell numbers (10th–90th %=
146–753 cells/μl; Table 1 and Fig. 1d). By contrast, the
naïve CD8+ T cell percentage and absolute number
were constantly low with limited variability (median=
6 %, 10–90th %=1–21 % and median=18.4 cells/μl,
10th–90th % =4–68 cells/μl, respectively) (Fig. 1b).
Interestingly, the two subsets of antigen-experienced
CD8+ T cells showed a distinct pattern: greater inter-
individual variability of CD28−CD95hi EM T cell
numbers (10th–90th %=53–524 cells/μl) as compared
to CD28+CD95hi CM T cell numbers (10th–90th %=
45–224 cells/μl) (Fig. 1d). Notably, it was observed that
both percentages and numbers of total CD8+ T cells
were mostly dictated by variation of CD28− EM CD8+
T cells (Fig. 1c, e). Collectively, these results indicated
that CMV+aged subjects exhibited broad variability in
CD8+ T cell number, which mainly reflected the vari-
ability in their CD28−CD95hi compartment.
Progressive age correlates with the loss of naïve CD8 T
cells in CMV+subjects
The effect of age on inter-individual T cell and CD8+
subset variability was explored by correlating the per-
centages (Fig. S1) and the absolute numbers (Fig. 2) of
each subset with the age of the subjects. We found that
percentages of lymphocytes significantly decreased with
age, while the percentages of CD3+, CD4+ and CD8+ T
cells did not significantly change (Fig. S1a–d). As ex-
pected, amongst the CD8+ T cell compartment, a signif-
icant age-related decrease in the naïve T cell percentages
was mirrored by an increase in the antigen-experienced T
Table 1 Study subject characteristics
Value
Number of subjects 131
Age [y, mean (min–max)] 81.3 (60–100)
Gender (% of females) 60.3
CMV-IgM (% of positive) 0













Naive CD8+ 6e (0.04–54.1)
18.4a (0.13–140.7)
CM CD8+ 37e (5.9–85.6)
115.3a (17–423)
EM CD8+ 53.5e (6.6–92)
173.4a (5.8–794)
Naïve, CM and EM CD8+ subsets are defined in “Methods”
a Number of cells/μl, median (min–max)
b% among WBC, median (min–max)
c% among total Lymphocyte, median (min–max)
d% among total CD3+, median (min–max)
e% among total CD8+, median (min–max)
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cell percentages (Fig. S1e, f). Interestingly, this accumu-
lation reflected the increase in CD28− EMTcell percent-
ages, while CD28+ CM T cell percentages did not
change (Fig. S1g, h). When we looked at the absolute
numbers (Fig. 2), we found several different results: total










































































































Fig. 1 Variability of CD8 Tcell subsets in CMV-infected subjects
aged over 60 years. a Representative flow cytometry plots of
phenotypic analysis from a 79-year-old old subject. Heparinized
whole blood were stained as described in “Methods”. b Box plots
show the percentages and d absolute numbers (median, 25th and
75th percentiles, and bars above and below the box, the 10th and
90th percentiles) of total and different CD8+ T cell subsets, deter-
mined in all subjects. c The correlations of percentages and e
absolute numbers of total CD8+ T cells with CD28− EM T cells
were assessed by Spearman’s rank test. In each plot, Spearman’s
rank correlation coefficient (rs) and the line of best fit are shown. A
p value <0.05 was considered significant
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p = 0.013
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p =0 .001
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Fig. 2 Relationship between age and alterations in CD8 T cell
subset abundance. Absolute numbers of each circulating popula-
tion are represented in correlation with the subject age. All the
correlations were assessed by Spearman’s rank test. Spearman’s
rank correlation coefficients (rs) and the line of best fit are shown.
p values <0.05 were considered significant
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CD4+ Tcells significantly decreased with age (Fig. 2a–c),
while the numbers of CD8+ T cells did not significantly
change (Fig. 2d). Amongst the CD8+ T cell subset, naïve
CD8+ T cell numbers progressively declined with age
(Fig. 2e). By contrast, antigen-experienced CD8+ T cell
numbers, including both the CD28+ CM and CD28− EM
T cell numbers, did not significantly change within this
interval (Fig. 2f, g, h). Hence, CMV+subjects aged over
60 years exhibited a significant age-related reduction of
naïve CD8+ T cells, both as percentage and as absolute
number, whereas the antigen-experienced T cell expan-
sion was only in terms of percentages, without age-related
absolute modifications of either CM or EM CD8 T cells.
Numbers of CD8+ T cells reactive to pp65 and IE-1
correlate with the accumulation
of the antigen-experienced CD8 T cells
One of the main objectives of the study was to obtain
insights into the impact of anti-CMV CD8+ T cell re-
sponses on CD8+ T cell subsets distribution. To this end,
we used both pMHCmultimer staining and functional ICS
assays. pMHCmultimers detect antigen-specific responses
to selected HLA-class I restricted immunodominant epi-
topes, whereas ICS measure global responses to entire
proteins, using peptide mixes covering the entire protein
length. For these latter assays, we stimulated the PBMC of
all recruited donors with the commercially available pep-
tide mixes covering pp65 and IE-1 CMV proteins, to
evaluate the percentage (Fig. S2) and the absolute number
of antigen-specific IFN-γ producing CD8+ T-cells
(Fig. 3a). In 100 of 131 subjects (76.3 %) who had a
pp65- and/or a IE-1-specific response, we correlated the
absolute numbers of functional antigen-specific CD8+ T
cells with the absolute number of CD8+ Tcells, naïve and
antigen-experienced (total memory) CD8+ T cells
(Fig. 3b). Absolute numbers of IFNγ+ antigen-specific
CD8+ T cells exhibited significant positive correlation to
both CD8+ T cell absolute number and total memory
(CD95hi) CD8+ T cell absolute number, but showed no
correlation to the number of naïve CD8+ T cells. In sub-
jects bearing HLA-A2 and/or -B7, staining with the HLA-
A*0201 /CMV pp65 ( 495–503 ) a nd HLA-
B*0702/CMVpp65(417–426) and CD28 allowed us to
separate anti-pp65pentamer+T cells into antigen-specific
CD28+ CM and CD28− EM T cells (Fig. 3c). 51/67
subjects (76.1 %,) had anti-pp65pentamer+CD8+ T cells
that we could correlate with absolute number of the CD8+
T cell subsets. Similarly to functional responses, overall
anti-pp65pentamer+CD8+ T cell absolute number exhib-
ited significant positive correlation to both the CD8+ Tcell
absolute number and the antigen-experienced CD8+ Tcell
absolute number, again without significant correlationwith
naïve CD8+ T cell numbers (Fig. 3d). Delineation of anti-
pp65pentamer+CD8+ T cell according to CD28 expres-
sion showed a significant positive correlation both between
antigen-specific and total CD28+ CM T cell subset and
between antigen-specific and total CD28− EM T cell
subset (Fig. 3e). In summary, these results strongly indi-
cated that number of functional anti-pp65 plus IE-1 CD8+
T cells, as well as the number of anti-pp65pentamer+
CD8+ T cells, were related to absolute number of total
antigen-experienced CD8+ T cells, but not to naïve CD8+
T cell number.
Relationship between age and anti-CMV immune
responses in study subjects
Memory inflation of anti-CMV CD8+ T cell responses
during human aging has been reported by several studies
comparing elderly to middle aged and young subjects.
Nevertheless, it is unclear whether such a tendency to
accumulate anti-CMV CD8+ T cell responses is further
modulated by aging. As shown in Fig. 4, when we corre-
lated the anti-CMVCD8+ Tcells with age in our cohort of
donors aged over 60 years, neither the percentages nor
Fig. 3 Relationship between anti-CMV CD8+ Tcell responses and
alterations in CD8 T cell subset abundance. a Representative flow
cytometry plots of functional anti-CMV CD8+ T cells from a 76-
year-old subject. PBMCs were stimulated for 5 h with mixtures of
peptides spanning the sequence of pp65 and IE-1 CMV proteins and
stained as described in “Methods”. b Absolute numbers of each
CD8+ T cell subset are represented in correlation with the absolute
numbers of functional anti-CMVCD8+ Tcells, identified as the sum
of anti-pp65 and anti-IE-1 IFN-γ producing CD8+ T cells. c Repre-
sentative flow cytometry plots of anti-pp65 pentamer+CD8+ Tcells
from an 85-year-old subject. PBMCs of HLA-A2 (not shown) and
HLA-B7 positive subjects (this panel) were stained with p-MHC
anti-pp65pentamers as described in “Methods”. dAbsolute numbers
of each CD8+ T cell subset are represented in correlation with the
absolute numbers of anti-pp65pentamer+CD8+ T cells. e The
antigen-experienced CD8+ T cells are dissected to depict CD28+
CM and CD28− EMTcells and absolute numbers are represented in
correlation with the absolute numbers of anti-pp65pentamer+
CD28+ CM T cells and anti-pp65pentamer+CD28− EM T cells.
All the correlations were assessed by Spearman’s rank test. The
Spearman’s rank correlation coefficients (rs) and the line of best fit
are shown. Both the functional anti-CMVand anti-pp65pentamer+
CD8+ T cell absolute numbers are shown in a log-scale. p values
<0.05 were considered significant

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absolute numbers of anti-CMVCD8+ Tcells, evaluated as
functional (Fig. 4a, b) or as anti-pp65pentamer+
(Fig. 4c, d) T cells, significantly changed with age. The
same result was found when considering percentages or
absolute numbers of anti-pp65pentamer+CM T cells
(Fig. 4e, f) and anti-pp65pentamer+EM T cells
(Fig. 4g, h). Thus, data did not highlight any further
increase in anti-CMV CD8+ T cell responses during the
last decades of life. Rather, the values of anti-CMVCD8+
T cell responses indicated broad inter-individual variabil-
ity (10th–90th %=1–30 cells/μl and 0.3–37 cells/μl, re-
spectively, for functional and anti-pp65 T cell absolute
numbers), which was not related to age. When we con-
sidered anti-CMV humoral responses, as previously de-
scribed, a significant age-related increase of CMV-
specific IgG was found (Fig. S3). Interestingly, the corre-
lations of CMV-specific IgG with both the percentages or
the absolute numbers of functional anti-CMV CD8+ T
cells (Fig. S3b, c) as well as with both percentages and
absolute numbers of anti-pp65pentamer+CD8+ T cells
(Fig. S3d, e), were not significant. These results
underlined the lack of a significant association between
the anti-CMV humoral response intensity and the CMV-
specific CD8+ T cell responses evaluated in this study.
Multiple regression models to investigate
the inter-individual variability of CD8+ T cell subsets
In order to investigate the basis for the broad inter-
individual variability of CD8+ T cell subsets, we tested
the contribution of several variables through multiple
regression analyses. In a preliminary analysis we exam-
ined all the following predictors: age, either functional
anti-CMV CD8+ T cell absolute number or anti-
pp65pentamer+T cell absolute number, anti-CMV IgG
titer, gender, educational level and health status. By using
backward elimination we found that the dependent vari-
ables (number of total, naïve, and antigen-experienced
CD8+ T cells), were significantly predicted only by age
and number of anti-CMV CD8+ T cell, but not by anti-
CMV IgG Ab level, gender, educational level or health
status (data not shown). On this basis, we present the
results with only age and anti-CMV CD8+ T cells as
predictors for variability of CD8+ T cell subsets. Results
shown in Table 2 highlight that: (a) functional anti-CMV
CD8+ T cell absolute number was a significant predictor
of the whole CD8+ T cell absolute number (R2=0.197,
p=0.0001), regardless of age; (b) age was a significant
predictor of naïve CD8+ T cell absolute number (R2=
0.308, p=0.0001) with a reduction of 1.4 naïve Tcells/μl
per year (95 % confidence interval: −0.97 to 1.83),
regardless of CMV-specific CD8+ T cell absolute num-
ber; (c) functional anti-CMV CD8+ T cell absolute num-
ber was a significant predictor of antigen-experienced
(total memory) CD8+ T cell absolute number (R2=
0.214, p=0.0001), regardless of age. The same analysis
using the pMHC multimer assay (Table 3), showed that:
(a) anti-pp65pentamer+T cell absolute number was a
significant positive predictor of the absolute accumula-
tion of CD8+ T cells (R2=0.222, p=0.0006), regardless
of age; (b) age was a significant predictor of the absolute
loss of naïve CD8+ T cells (R2=0.488, p=0.0001), re-
gardless of the anti-pp65pentamer+T cell absolute num-
ber; (c) anti-pp65pentamer+Tcell absolute number was a
significant predictor of antigen-experienced (total mem-
ory) CD8+ Tcell absolute number (R2=0.23, p=0.0005),
regardless of age. In addition, separate evaluation of anti-
pp65pentamer+EM CD8+ T cells made it possible to
define epitope-specific CD28− T cells as an independent
predictor of absolute numbers of total EM CD8+ cells
(R2=0.213, p=0.0014), regardless of age. By contrast,
anti-pp65pentamer+CM T cell absolute number could
not significantly predict variation of total CM CD8+ T
cell absolute numbers (R2=0.076, p=0.0691).
Discussion
The impact of CMV infection on human immune func-
tion and health in later life is a subject of intense current
research (Pawelec et al. 2010). It has been hypothesized
that the manner in which CMV and the host immune
system interact may be critical in determining the age
and/or functional fitness of adaptive immunity and
hence human longevity (Gress and Deeks 2009;
Pawelec et al. 2006). Then, a challenge is to discriminate
Fig. 4 Relationship between age and anti-CMV CD8+ T cell re-
sponses in advanced aging. a Percentages and b absolute numbers of
functional anti-CMV T cell responses are correlated with age. c
Percentages and d absolute numbers of anti-pp65pentamer+T cells
are correlatedwith age. Anti-pp65pentamer+Tcells were separated to
denote anti-pp65pentamer+CM and anti-pp65pentamer+EM T cells
and percentages (e and f, respectively), or absolute numbers (g and h,
respectively), are represented in correlation with age. All the correla-
tions were assessed by Spearman’s rank test. The Spearman’s rank
correlation coefficients (rs) and the best fit are shown. Both the
functional anti-CMV and anti-pp65pentamer+CD8+ T cell absolute
numbers are shown in a log-scale. p values <0.05 were considered
significant
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and quantify the contribution of CMV–immune system
interaction from the sole effects of aging itself. This
cross-sectional study provides new insights into the
specific influences of aging and anti-CMV responses
shaping peripheral blood CD8+ T cell subset homeosta-
sis in CMV-seropositive subjects in their last four de-
cades of life. In particular, we contribute to define a clear
separation between forces dictating the altered profile of
naïve and antigen-experienced CD8+ T cell subsets in
the elderly with CMV.
This study showed that anti-CMV specific CD8+ T
cells responses may not further increase with advancing
age. In the mouse models of herpesvirus infection,
“memory inflation” has been shown to depend on viral
antigen (Snyder et al. 2008; Lang et al. 2009) and
modulated by the control of viral replication (Lang
et al. 2009), but the age of the animal may not be
predictive of the extent of inflation (Lang and
Nikolich-Zugich 2011). Also, an observational cross-
sectional study in the rhesus macaques model (Cicin-
Sain et al. 2011) has revealed a rather constant magni-
tude of anti-CMV CD8+ T cell responses in later life.
Even previous studies in humans have shown findings
consistent with this notion. Khan et al. (2004) had
reported more significant age-related increases in
pMHC-measured anti-CMV CD8+ responses to multi-
ple immunodominant epitopes between young (20–
40 years) and adults (40–60 years), than between adults
and aged subjects (>60 years). Likewise, in a previous
study of ours (Vescovini et al. 2007) showing age-
related expansion of cumulative anti-CMV CD4+ and
CD8+, IFN-γ and TNF-α producing T cells, the
Table 2 Multiple regression
analysis fitting age and functional
anti-CMV CD8+ T cell absolute
number as predictors for CD8+ T
cell subset absolute numbers
β coefficient p value 95 % CI
CD8+ T cell
Age 0.879 0.6988 (−3.616, 5.374)
Number of functional anti-CMV CD8+ T cell/μl 6.719 0.0001 (3.97, 9.613)
Naïve CD8+ T cell
Age −1.4 0.0001 (−1.829, −0.972)
Number of functional anti-CMV CD8+ T cell/μl −0.018 0.8953 (−0.287, 0.251)
Antigen-experienced CD8+ T cell
Age 2.274 0.3081 (−2.131, 6.679)
Number of functional anti-CMV CD8+ T cell/μl 6.775 0.0001 (4.01, 9.54)
Table 3 Multiple regression
analysis fitting age and anti-
pp65pentamer+T cell absolute
number as predictors for CD8+ T
cell subset absolute numbers
β coefficient p value 95 % CI
CD8+ T cell
Age −2.009 0.5099 (−8.092, 4.075)
Number of anti-pp65pentamer+/μl 3.906 0.0006 (1.783, 6.03)
Naïve CD8+ T cell
Age −1.795 0.0001 (−2.343, −1.247)
Number of anti-pp65pentamer+/μl −0.014 0.887 (−0.205, 0.178)
Antigen-experienced CD8+ T cell
Age −0.216 0.9428 (−6.226, 5.795)
Number of anti-pp65pentamer+/μL 3.885 0.0005 (1.787, 5.983)
CD28+ CM CD8+ T cell
Age −1.195 0.3183 (−3.577, 1.188)
Number of pp65pentamer+CD28+ CM/μl 3.857 0.0691 (0.314, 8.027)
CD28− EM CD8+ T cell
Age 1.174 0.6394 (−3.834, 6.182)
Number of pp65pentamer+CD28- EM/μl 3.538 0.0014 (1.445, 5.63)
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selective increase of functional CD8+ T cells was sig-
nificant between adults and early aged (65–85 years),
but not between the latter category and oldest old sub-
jects (>85 years). Lastly, in another study conducted in
subjects of different health condition across later life
(Vescovini et al. 2010), we could not detect significant
increase in memory inflation due to either age or to
health. Therefore, although the notion that elderly main-
tain greater numbers of anti-CMV CD8+ T cells than
young subjects is undisputable, current data suggest that
later phases of life may not be necessarily accompanied
by endless expansion of anti-CMV CD8+ T cells. This
concept will need to be confirmed by longitudinal stud-
ies addressing the dynamic at the individual level
throughout late age, however observation so far extend-
ed to a few years of follow-up have not reported signif-
icant alterations (Iancu et al. 2009; Miles et al. 2008;
Wallace et al. 2011), even in subjects approaching the
end of life (Hadrup et al. 2006).
Naïve CD8+ T cell homeostasis and its age-related
deregulation are likely relevant for primary immune
responses, for vaccination strategies and possibly for
survival even in advanced age (Ferrando-Martinez
et al. 2011, 2013). Results in this paper, showing no
influence of anti-CMV reactivity on naive T cells, are
apparently inconsistent with the current notion that
CMV infection plays an active role in depleting the
naive T cell pool. Indeed, several reports have docu-
mented that subjects with CMV retain significantly few-
er naïve T cells than age-matched uninfected subjects,
particularly when relative population representation is
evaluated (Almanzar et al. 2005; Chidrawar et al. 2009;
Derhovanessian et al. 2010, 2011; Litjens et al. 2011;
Sauce et al. 2009), whereas primary CMV infection
induces a sudden drop of the percentage of naïve Tcells,
regardless of age (van de Berg et al. 2010). Also, a
recent report by Lachmann et al. (2012) showed that
even size of pp65-specific CD8+ T cell response corre-
lated significantly with a relative loss of naive T cells. It
is uncertain whether this widely reported CMV-related
depletion of CD8+ naive T cells may occur simply
because of massive naïve T cell recruitment in primary
infection, or rather because of other effects in chronic
infection (Vezys et al. 2006). Synergistic detrimental
effects by CMV chronic infection could consist in en-
hanced consumption of naïve T cells with reduced sup-
ply of novel naïve T cells by declining thymic function
(Gress and Deeks 2009). Also, naïve T cells may have
their “immunological space” usurped by expanded anti-
CMV CD8+ T cells. If any of these hypothetical plau-
sible scenarios were in play, numbers of naïve T cells
would be expected to inversely correlate with the size of
anti-CMV responses. But we did not observe any sig-
nificant correlation between size of anti-pp65 and anti-
IE-1 CD8+ T cells and CD8+ naive T cells (Fig. 3 and
Tables 2 and 3), thus ruling out such a hypothesis.
Likewise, another cross-sectional study of large num-
bers of CMV−and CMV+subjects (Wertheimer et al.,
submitted for publication) is confirming that persistent
CMV infection neither engages significant numbers of
naïve T cells, nor contributes to accelerate physiological
age-related naïve T cell loss. Furthermore, two recent
reports (Chidrawar et al. 2009; Litjens et al. 2011) have
shown that differences in naïve T cells numbers between
CMV-negative and CMV-positive subjects may be quite
constant throughout adulthood and aging. So, when con-
sidering all previously published papers as well as current
results, the overall likely hypothesis is that CMV-driven
depletion of naive CD8+ T cells derives from recruitment
of anti-CMV naïve CD8+ Tcells into antigen-experienced
CD8+ T cells during primary infection. Once most CMV-
specific naïve T cells have been mobilized in the early
phase of infection, remaining naïve CD8 T cells still
circulating in elderly people are neutral to anti-CMV
responses because they carry TCR specificities irrelevant
to CMV antigens. Finally, regardless of CMV-driven
CD8+ naive T depletion, one main aspect of these data
is that the tiny immunological space occupied by naïve
CD8+ T cells was not endangered by expanded antigen-
experienced CD8+ T cells.
The expanded immunological space of antigen-
experienced CD8+ T cells was still characterized by
broad individual variability of CD8+CD28− T cells
(Figs. 1 and 2) although all subjects were selected as
CMV-seropositive. Remarkably, variation of the CD8+
CD28− EM T cell subset strictly correlated with whole
CD8+ T cells (Fig. 1c, e). Notably, we found that the
size of the CD28−CD8+ T cell subset was predicted by
CD8+ T cell reactivity to immunodominant epitopes of
pp65 antigen. By contrast, none of the other variables
considered in this study, including age, gender, health
status, educational level (as an indirect socioeconomic
status indicator) and anti-CMV IgG Ab level, revealed
to be significant in this regard. These results confirm and
extend the previous findings by Lachmann et al. (2012)
in a smaller cohort showing that the degree of advanced
T cell memory differentiation correlates with the actual
size of CD4 and CD8 anti-pp65 T-cell responses.
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Moreover, we found that antigen-experienced CD8+ T
cell numbers, including not only CD28− but also
CD28+ CD8+ T cells, were significantly predicted by
INF-γ responses to overlapping peptides of entire pp65
and IE-1 proteins. In spite of differences between
pMHC staining and ICS assay, results obtained by both
methods were highly consistent and predicted size var-
iability of memory/effector CD8+ T cells, thus strength-
ening our conclusions. It should be noted that these
results are somewhat surprising when considering the
limited extent of antigen-specificity to which they were
tested, and should be considered preliminary for this
reason. Nevertheless, after demonstration by several re-
ports of common alterations in CD8+ T cell subsets
conferred by CMV-seropositivity, this study illustrates
that CD8+ T cell reactivity to just two well-known
immunodominant antigens (pp65 and IE-1) explains a
significant degree of the individual variability of antigen-
experienced, CD28−CD8+, and whole CD8+ T cells.
The origin of inter-individual variability of CD8+ T
cell responses to pp65 and IE-1 remains unclear.
Interestingly, it has been recently reported that subjects
genetically enriched for longevity are less susceptible to
the characteristic CMV-associated antigen-driven im-
mune alterations commonly considered to be the hall-
marks of immunosenescence (Derhovanessian et al.
2010). Other factors independent from genetic predis-
position could also play roles, such as: length of time
from primary infection, distinct CMV viral strains
(Pignatelli et al. 2010), site of viral persistence (Leng
et al. 2011), degree of thymic involution and naive Tcell
reservoir faced with primary infection (Pitcher et al.
2002; Sauce et al. 2009), different individual behaviours
regarding physical exercise (Turner et al. 2010) and/or
caloric intake (Messaoudi et al. 2006), prior events of
lymphodepletion counteracted by T lymphocyte ho-
meostatic mechanisms (Fagnoni et al. 2002).
Regardless of origin(s) of individual variability, we have
seen that CMV-driven CD8+ T cell reactivity is corre-
lated with increasing numbers of late differentiated
CD28−CD8+ T cells. This parameter make up a sub-
stantial part of the highly discussed Immune Risk
Phenotype (IRP) considered for the potential prediction
of increased morbidity and death (Wikby et al. 2002).
As CMV-driven immunosenescence and IRP may be
considered biomarkers of the emerging pathological role
of CMV in accelerating senescence, findings from this
study may help to design appropriate interventional
therapeutic protocols in selected CMV-seropositive
subjects to target CMV-sensitive endpoints still poten-
tially reversible.
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